ClinStar is a leading contract research organization (CRO) in emerging markets with extraordinarily fast patient enrollment, higher quality and passion for customer service. Headquartered in San Francisco, ClinStar manages Phase I-IV clinical research trials in Russia, Ukraine, Belarus and the Baltic States.
From regulatory submissions to clinical affairs, medical monitoring, drug storage and distribution, ClinStar offers fully integrated services for managing client trials. The company is best known as a Western CRO in Eastern Europe providing faster patient recruitment and higher quality data than that provided in the West.
Business Day TV Highlights the ClinStar Business Model
Over the past ten years, ClinStar has developed a highly effective business model that combines Western management style with local operational focus. Unlike many global CROs, ClinStar has a strong local presence in all functional areas of operations. This has allowed the company to develop unique know-how of local requirements, processes and business culture. ClinStar cultivates personal relationships that it utilize to help its clients save time and money.
Business Day TV show discussed how in a competitive CRO marketplace, ClinStar also differentiates itself by providing unsurpassed client orientation. The company’s dedicated, specialized teams are always available to its clients despite the time zone differences. Every client, whether a small virtual biotech or a large pharma company, receives the same undivided attention, respect and commitment to excellence.
The ClinStar Mission and Vision
ClinStar’s mission is to assist its clients in bringing new, innovative, preventative and curative products to market faster – and in a socially responsible manner – while providing clinical trial participants with access to diagnostics and treatments to which they would otherwise have limited access.
Business day TV with Terry Bradshaw talked about ClinStar’s vision to be the most effective, efficient and trusted clinical trial services provider in the emerging markets of Russia, Ukraine, Belarus and the Baltic States. ClinStar will become a global provider while retaining local focus.
Why ClinStar for Clinical Trials in Russia?
Selecting the right partner with proper expertise is a critical first step toward success within Russia and Eastern Europe. Companies choose ClinStar because it recruits patients quickly, produces high-quality data and has always maintained a client-centered approach.
When ClinStar first began its operations in 2000, it spent a lot of time discussing with its clients the benefits of conducting clinical trials in Russia and Ukraine. With a combined population of 200 million, and a centralized healthcare system, millions of patients are eager to participate in clinical trials. Experienced and well-educated physicians are keen to conduct these trials, and do them well.
Clinical Trial Investigators
ClinStar’s expanding database includes more than 700 investigators. The company’s local presence allows it to establish close ties with investigators, in order to make certain that recruitment, data collection and analysis all run smoothly. ClinStar’s training and regular follow-up with investigators guarantees that all protocols are followed consistently and client studies end on time.
Business Day TV highlights ClinStar’s Vast Experience
ClinStar’s experience includes studies in:
- Cardiovascular Diseases
- Endocrinology and Metabolic Diseases
- Oncology and Hematology
- Infectious Diseases
- Hepatic Diseases
- Pulmonary Diseases
- Autoimmune Disorders
- Pediatric Trials
ClinStar offers valuable experiences and strong medical backgrounds to enhance client study across almost all major therapeutic areas. Business Day TV show reviewed that while the company’s focus is on the geography rather than any particular therapeutic areas, ClinStar’s trial experience covers all aspects of Phase I to IV clinical trials and a broad range of specialties. Since ClinStar’s inception, it’s managed more than 100 trials.